Daniel Wolfson, MHSA, spoke with the Journal of Clinical Pathways about the pervasive issue of duplicative or unnecessary treatment in health care.
Journal of Clinical Pathways spoke with two leaders at the Dana-Farber Cancer Institute about their experiences implementing clinical pathways.
Howard L Kaufman, MD, discussed what the future holds for immunotherapies and the role they will likely play within pathways.
Robin T Zon, MD, spoke on the ASCO policy statement on clinical pathways and the areas in which pathways most need to improve.
Journal of Clinical Pathways spoke with Geoffrey P. Dunn, MD, about the growth of formal palliative care programs.
The National Committee for Quality Assurance (NCQA) is heading what is a new way of looking at health care, the patient-centered medical home (PCMH).
Piedmont Heart Institue developed one of the premiere methods for transcatheter aortic valve replacement, demonstrating improved outcomes and lower associated costs.
Robert Carlson, MD, and Joan McClure, MS, spoke about what factors led to the development of NCCN Evidence Blocks and future plans.
JCP discusses with Hagan her concerns regarding the current structure of our health care industry.
Richard Schilsky, MD, FACP, FASCO, spoke about the forces that led to the development of the ASCO Value Framework and considerations that influenced its design.